RHOA and Behcet disease: BD downregulates synaptic‐plasticity‐related proteins (Nogo‐A, NgR, RhoA, AGG, and CRMP2) and attenuates oligodendrocyte‐mediated inhibitory signaling via reduced NgR/Olig2 co‐localization.